![](/img/cover-not-exists.png)
Management of NSCLC Disease Progression After First-Line EGFR Tyrosine Kinase Inhibitors: What Are the Issues and Potential Therapies?
Califano, Raffaele, Romanidou, Ourania, Mountzios, Giannis, Landi, Lorenza, Cappuzzo, Federico, Blackhall, FionaVolume:
76
Language:
english
Journal:
Drugs
DOI:
10.1007/s40265-016-0578-z
Date:
May, 2016
File:
PDF, 478 KB
english, 2016